Kiora Pharmaceuticals's top three insider shareholders as of September 29, 2026 are Brian M. Strem (President And Ceo, 58.82K shares), Eric Joseph Daniels (Chief Development Officer, 31.74K shares), Melissa Tosca (Cfo, 26.06K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Brian M. Strem | President And Ceo | 58,823 | 0 | 58,823 | 44.4% | 02 Jul, 2026 |
| 2 | Eric Joseph Daniels | Chief Development Officer | 31,741 | 0 | 31,741 | 23.9% | 02 Apr, 2026 |
| 3 | Melissa Tosca | Cfo | 26,064 | 0 | 26,064 | 19.7% | 02 Jul, 2026 |
| 4 | Erin Parsons | Director | 0 | 5,260 | 5,260 | 4.0% | 13 Jun, 2024 |
| 5 | Praveen Tyle | Director | 5,014 | 0 | 5,014 | 3.8% | 19 Aug, 2024 |
| 6 | Aron Shapiro | Director | 0 | 3,000 | 3,000 | 2.3% | 11 Sep, 2024 |
| 7 | Carmine N. Stengone | Director | 1,250 | 0 | 1,250 | 0.9% | 12 Sep, 2024 |
| 8 | Lisa Walters-Hoffert | Director | 1,250 | 0 | 1,250 | 0.9% | 20 Aug, 2024 |
| 9 | Stephen From | Executive Chairman | 113 | 0 | 113 | 0.1% | 06 Jan, 2022 |
| 10 | Sarah Romano | Chief Financial Officer | 38 | 0 | 38 | 0.0% | 11 Feb, 2022 |
| 11 | Brenda Mann | Vp Of Research Development | 25 | 0 | 25 | 0.0% | 03 Nov, 2021 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Sep, 2026 | Keith J. Lane | Other | Acquired A | 55,000 | $0.00 | $0 | 55,000 | Direct |
| 01 Jul, 2026 | Melissa Tosca | Cfo | Disposed F | 911 | $2.66 | $2.42K | 26,064 | Direct |
| 01 Jul, 2026 | Brian M. Strem | President And Ceo | Disposed F | 1,869 | $2.66 | $4.97K | 58,823 | Direct |
| 10 Jun, 2026 | Carmine N. Stengone | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 10 Jun, 2026 | Erin Parsons | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 10 Jun, 2026 | Lisa Walters-Hoffert | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 10 Jun, 2026 | David Hollander | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 10 Jun, 2026 | Aron Shapiro | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 10 Jun, 2026 | Praveen Tyle | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 01 Apr, 2026 | Brian M. Strem | President And Ceo | Disposed F | 1,906 | $1.95 | $3.72K | 60,692 | Direct |
| 01 Apr, 2026 | Eric Joseph Daniels | Chief Development Officer | Disposed F | 929 | $1.95 | $1.81K | 31,741 | Direct |
| 01 Apr, 2026 | Melissa Tosca | Cfo | Disposed F | 929 | $1.95 | $1.81K | 26,975 | Direct |
| 06 Mar, 2026 | Brian M. Strem | President And Ceo | Acquired A | 16,733 | $0.00 | $0 | 62,598 | Direct |
| 06 Mar, 2026 | Melissa Tosca | Cfo | Acquired A | 6,533 | $0.00 | $0 | 27,904 | Direct |
| 06 Mar, 2026 | Eric Joseph Daniels | Chief Development Officer | Acquired A | 6,533 | $0.00 | $0 | 32,670 | Direct |
| 06 Mar, 2026 | Melissa Tosca | Cfo | Acquired A | 13,067 | $0.00 | $0 | 13,067 | Direct |
| 06 Mar, 2026 | Eric Joseph Daniels | Chief Development Officer | Acquired A | 13,067 | $0.00 | $0 | 13,067 | Direct |
| 06 Mar, 2026 | Brian M. Strem | President And Ceo | Acquired A | 33,467 | $0.00 | $0 | 33,467 | Direct |
| 03 Mar, 2026 | Eric Joseph Daniels | Chief Development Officer | Disposed F | 238 | $2.02 | $481 | 26,137 | Direct |
| 03 Mar, 2026 | Brian M. Strem | President And Ceo | Disposed F | 238 | $2.02 | $481 | 45,865 | Direct |